DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Advanced Enzyme Technologies Limited — Board Meeting Intimation

NSE 3 hrs ago·1 Aug 2026, 7:22 am

Company NSE

Advanced Enzyme Technologies Limited has announced a board meeting scheduled for August 8, 2026, to review its unaudited financial results for the quarter ending June 2026. The agenda also includes considering a share buyback proposal.

This announcement is a routine corporate update, but it is significant for investors as it provides a preview of the company's financial health and capital allocation strategy for the near term.

Investors should watch for the specific buyback price and the number of shares the company intends to repurchase. These details will be crucial in determining the attractiveness of the offer for existing shareholders.